乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

ASCO Video Pearls: CLL

<乌鸦传媒 class="page-description">Video Pearls from the American Society of Clinical Oncology
Real-World Analysis of Race in CLL Treatment Patterns

Prognostic testing, closer monitoring of Black patients crucial, says Jacqueline Barrientos, MD

image
<乌鸦传媒 class="section_title">Latest ASCO Video Pearls: CLL Meeting Coverage
More Data Needed for Treatment Sequencing in CLL

We need more information on second-line treatment, says Barbara Eichhorst, MD

July 5, 2022
Novel Ibrutinib Combo Shows High Response Rates in MCL, CLL

Hun Ju Lee, MD, breaks down the data on ibrutinib plus zilovertamab

June 28, 2022
Durable Remissions in CLL With Fixed-Duration Triplet at 4 Years

Kerry Rogers, MD, discusses the next steps with obinutuzumab, ibrutinib, and venetoclax

June 20, 2022
<乌鸦传媒 class="section_title"> Latest Oncology/Hematology Meeting Coverage